stockrowDIH Holding US, Inc.
DHAIDIH Holding US, Inc.’s revenue for fiscal 2025 (year ended March 2025) was $62.9 million, down 2.50% from fiscal 2024.
- Revenue
- −30.7%
- EPS
- +43.1%
- Free cash flow
- −167.9%
Quarter to March 2025, against a year earlier
Follow DHAI
Alert me
DIH Holding US, Inc. (DHAI) Piotroski F-score
DIH Holding US, Inc.'s Piotroski F-score for fiscal 2025 is 4 out of 9: 4 of nine tests of profitability, leverage and efficiency passed.
Piotroski F-score, annual
Embed this chart
Annual newest first
| Period | Piotroski F-score | Change (points) |
|---|---|---|
| FY2025 | 4 | — |
How fiscal 2025’s score is made up
| Test | This year | Year before | Result | Points |
|---|---|---|---|---|
| Positive return on assets | (27.77%) | (25.01%) | Fail | 0 |
| Positive operating cash flow | (4.14m) | 5.19m | Fail | 0 |
| Rising return on assets | (27.77%) | (25.01%) | Fail | 0 |
| Cash flow above net income | 4.53m | 13.64m | Pass | 1 |
| Falling long-term leverage | 0.28 | 0.34 | Pass | 1 |
| Rising current ratio | 0.49 | 0.60 | Fail | 0 |
| No new shares issued | 1,430,197 | 1,055,288 | Fail | 0 |
| Rising gross margin | 51.24% | 46.18% | Pass | 1 |
| Rising asset turnover | 2.01 | 1.91 | Pass | 1 |
| Piotroski F-score | Mixed | 4 | ||
How the Piotroski F-score works
One point for each of nine tests, this fiscal year against the one before: positive return on assets, positive operating cash flow, rising return on assets, cash flow above net income, falling long-term leverage, a rising current ratio, no new shares issued, a rising gross margin and rising asset turnover. The ratios are the ones on this site, so each can be checked.
Joseph Piotroski (2000) called 8–9 high and 0–1 low; reading it in three bands is the common convention:
| 7–9 | Strong — most fundamentals improved |
|---|---|
| 4–6 | Mixed |
| 0–3 | Weak — most fundamentals deteriorated |
Where this differs from the paper: return on assets is on average rather than beginning-of-year assets, and weighted basic shares stand in for shares issued. The score is shown only when all nine tests can be worked out, which takes three fiscal years; banks and insurers, which report no current assets or gross profit, have none.
Piotroski F-score against peers
| Company | Piotroski F-score |
|---|---|
| NXL Nexalin Technology, Inc. compare | 5 |
| IVF INVO Fertility, Inc compare | 4 |
| DHAI DIH Holding US, Inc. | 4 |
| ICCM IceCure Medical Ltd. compare | 4 |
| GCTK GlucoTrack, Inc. compare | 3 |
| CODX Co-Diagnostics, Inc. compare | 2 |
| NUVOQ Holdco Nuvo Group D.G Ltd. compare | — |
| BJDX Bluejay Diagnostics, Inc. compare | — |
| ADGM Adagio Medical Holdings, Inc. compare | — |
What Piotroski F-score is
The Piotroski F-Score tells an investor how many signs of improving profitability, funding and efficiency a company shows against a year earlier.
One point for each of nine tests against a year earlier: positive return on assets, positive operating cash flow, rising return on assets, cash flow above net income, falling long-term leverage, rising current ratio, no new shares issued, rising gross margin, and rising asset turnover